---
figid: PMC5977110__cancers-10-00137-g002
figlink: /pmc/articles/PMC5977110/figure/cancers-10-00137-f002/
number: Figure 2
caption: 'Main proteins and pathways that influence YAP and TAZ in lung development
  and tumorigenesis. During lung development, the Crb3 polarity protein sequesters
  YAP and TAZ at the apical plasma membrane preventing their oncogenic function in
  the nucleus. Amot, a component of the tight junction complexes, exerts a similar
  function. GPCR receptors, EGFR receptor, and other RTKs, when activated by ligands,
  induce the RAS/RAF/MEK/ERK and the PI3K/AKT/mTOR pathways (inside a red rectangle),
  which, in turn, activate oncogenic YAP and TAZ through mechanisms either dependent
  on or independent of Hippo pathway core kinases (inside black rectangle). Upon DNA
  damage, cell contact, or other stress stimuli, RASSF1A activates the MST1/2-LATS1/2
  kinase cassete, inhibiting YAP and TAZ oncogenic function. In the nucleus, Vgll4
  inhibits the oncogenic role of YAP and TAZ through impairing YAP and TAZ binding
  with TEAD transcription factors. Arrows indicate activation of the indicated proteins,
  while blunt lines indicate repression of targeted proteins. Lines or arrows in red
  indicate signals which eventually activate nuclear YAP/TAZ, while lines or arrows
  in blue indicate signals or proteins which eventually inhibit nuclear YAP/TAZ, through
  mechanisms either dependent on or independent of Hippo pathway core kinases. Dashed
  arrows indicate reciprocal crosstalk. Abbreviations: MAPK, mitogen-activated protein
  kinase; RTK: receptor tyrosine kinase; EGF: epidermal growth factor; EGFR: EGF receptor;
  GPCR: G-protein-coupled receptor.'
pmcid: PMC5977110
papertitle: 'YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.'
reftext: Federica Lo Sardo, et al. Cancers (Basel). 2018 May;10(5):137.
pmc_ranked_result_index: '191460'
pathway_score: 0.958648
filename: cancers-10-00137-g002.jpg
figtitle: Main proteins and pathways that influence YAP and TAZ in lung development
  and tumorigenesis
year: '2018'
organisms: Homo sapiens
ndex: 083d512b-dee3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5977110__cancers-10-00137-g002.html
  '@type': Dataset
  description: 'Main proteins and pathways that influence YAP and TAZ in lung development
    and tumorigenesis. During lung development, the Crb3 polarity protein sequesters
    YAP and TAZ at the apical plasma membrane preventing their oncogenic function
    in the nucleus. Amot, a component of the tight junction complexes, exerts a similar
    function. GPCR receptors, EGFR receptor, and other RTKs, when activated by ligands,
    induce the RAS/RAF/MEK/ERK and the PI3K/AKT/mTOR pathways (inside a red rectangle),
    which, in turn, activate oncogenic YAP and TAZ through mechanisms either dependent
    on or independent of Hippo pathway core kinases (inside black rectangle). Upon
    DNA damage, cell contact, or other stress stimuli, RASSF1A activates the MST1/2-LATS1/2
    kinase cassete, inhibiting YAP and TAZ oncogenic function. In the nucleus, Vgll4
    inhibits the oncogenic role of YAP and TAZ through impairing YAP and TAZ binding
    with TEAD transcription factors. Arrows indicate activation of the indicated proteins,
    while blunt lines indicate repression of targeted proteins. Lines or arrows in
    red indicate signals which eventually activate nuclear YAP/TAZ, while lines or
    arrows in blue indicate signals or proteins which eventually inhibit nuclear YAP/TAZ,
    through mechanisms either dependent on or independent of Hippo pathway core kinases.
    Dashed arrows indicate reciprocal crosstalk. Abbreviations: MAPK, mitogen-activated
    protein kinase; RTK: receptor tyrosine kinase; EGF: epidermal growth factor; EGFR:
    EGF receptor; GPCR: G-protein-coupled receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - YWHAQ
  - ABL1
  - AKT2
  - AMOT
  - BTRC
  - AKT1
  - MAP2K2
  - MST1
  - CRB3
  - MAPK14
  - MTOR
  - STK3
  - AKT3
  - MAPK11
  - EGF
  - MAPK3
  - ABL2
  - MAP2K1
  - NRAS
  - RASSF1
  - MAPK8
  - TAZ
  - YY1AP1
  - MAPK9
  - MBTPS1
  - ARAF
  - RAF1
  - LATS1
  - RPTOR
  - EGFR
  - NMUR1
  - MAPK1
  - LATS2
  - STK11
  - LPA
  - MAPK12
  - BRAF
  - MAPK10
  - MAPK13
  - KRAS
  - HRAS
  - LPA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: ABL1
  symbol: ABL1
  source: hgnc_symbol
  hgnc_symbol: ABL1
  entrez: '25'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMOT
  symbol: AMOT
  source: hgnc_symbol
  hgnc_symbol: AMOT
  entrez: '154796'
- word: BTRCP
  symbol: betaTrCP
  source: hgnc_alias_symbol
  hgnc_symbol: BTRC
  entrez: '8945'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MST1/2
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: Crb3
  symbol: CRB3
  source: hgnc_symbol
  hgnc_symbol: CRB3
  entrez: '92359'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MST1/2
  symbol: MST2
  source: hgnc_alias_symbol
  hgnc_symbol: STK3
  entrez: '6788'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: EGF,growth
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ABL2
  symbol: ABL2
  source: hgnc_symbol
  hgnc_symbol: ABL2
  entrez: '27'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RASSF1
  symbol: RASSF1
  source: hgnc_symbol
  hgnc_symbol: RASSF1
  entrez: '11186'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: LPA
  source: MESH
  identifier: C522988
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
